Clinical Trial Update: Phase 2 Study Of Imetelstat for Patient With Myelodysplastic/Myeloproliferative Neoplasms [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for imetelstat in patients with myelodysplastic/myeloproliferative neoplasms; the study status is NOT_YET_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndromes
• Myeloproliferative Neoplasms

Drugs mentioned

• Imetelstat (imetelstat)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Phase II, Imetelstat | Phase 2 | Status: NOT_YET_RECRUITING